That would meet just about anybody's definition of a corporate 'success' Its_lose.
And no - NNVC is NOT there yet.
There have been numerous steps taken toward that definition of success - especially during the last year.
I count the demonstrated effectiveness of Flucide and Denguecide in animal models as among the positive steps that have been taken.
Submission of Flucide, and the beginning of TOX testing at BASi count as steps toward that goal.
Successfully completing scale-up in the Shelton plant to KG-quantities will be a significant step toward that goal.
A demonstration that Ebolacide2 has effectiveness against Ebola in cell and animal model systems will be another significant step toward that goal.
Submission of an IND to FDA for Flucide will be a huge step forward.
All of these are likely to happen over the course of the next few months (IND will be closer to a year IMO).
And each step forward lowers risk (perceived and otherwise) and brings the company closer to being able to generate revenue in ways other than selling stock or rights to as yet unachieved profits.